Statistics

Total Visits

Views
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.50

Select a period of time:

Number of views in the range

Views
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.7

Views

Views
November 20251
December 20250
January 20261
February 20260
March 20262
April 20261
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Brazil1
Morocco1
Mali1
Nigeria1
 

Top cities views

Views
Abakaliki1
Bamako1
Belo Horizonte1
Brooklyn1
Marrakesh1
Santa Clara1